The perioperative metabolic state is a key predictor of clinical outcome after cardiac surgery. In particular, stress hyperglycemia – an acute increase in blood glucose due to surgical and inflammatory stress reactions – correlates closely with increased complication and mortality rates. The stress hyperglycemia ratio (SHR) links acute glucose levels to long-term glycemic status (HbA1c), providing a robust method to estimate mortality risk in the short and long term. In this comprehensive summary, we present the key findings of the recent study by Pei et al [4] and discuss how SHR-based algorithms can help to identify patients early and make individualized treatment decisions.
Autoren
- Tanja Schliebe
Publikation
- CARDIOVASC
Related Topics
You May Also Like
- Preclinical Study on a Special Ginkgo biloba Extract
What role do proanthocyanidins play?
- Myasthenia gravis: immunomodulatory therapies for long-term treatment
Expanded Possibilities Thanks to Innovative Classes of Active Ingredients
- Interstitial Lung Diseases
Update on Idiopathic Pulmonary Fibrosis
- Plastic surgery and reconstructive microsurgery for DFS
Functional limb preservation between infection control, vascular medicine and resurfacing
- Ischemic stroke: Are smaller or larger brain arteries affected?
Recent study findings on intravenous lysis therapy with fibrinolytic agents
- Interview
“On par with the gold standards for trauma”
- Psychology: Emotional Freedom Techniques (EFT)
Emotional Healing Through Tapping
- Systemic Lupus (SLE): What Does the Diagnosis and Treatment Toolbox Have to Offer?